BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11151862)

  • 1. Economic considerations in the treatment of gastroesophageal reflux disease: a review.
    O'Connor JB; Provenzale D; Brazer S
    Am J Gastroenterol; 2000 Dec; 95(12):3356-64. PubMed ID: 11151862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cost-effectiveness analysis of prescribing strategies in the management of gastroesophageal reflux disease.
    Gerson LB; Robbins AS; Garber A; Hornberger J; Triadafilopoulos G
    Am J Gastroenterol; 2000 Feb; 95(2):395-407. PubMed ID: 10685741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton pump inhibitors or histamine-2 receptor antagonists for the prevention of recurrences of erosive reflux esophagitis: a cost-effectiveness analysis.
    Harris RA; Kuppermann M; Richter JE
    Am J Gastroenterol; 1997 Dec; 92(12):2179-87. PubMed ID: 9399748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re-examination of the cost-effectiveness of surgical versus medical therapy in patients with gastroesophageal reflux disease: the value of long-term data collection.
    Arguedas MR; Heudebert GR; Klapow JC; Centor RM; Eloubeidi MA; Wilcox CM; Spechler SJ;
    Am J Gastroenterol; 2004 Jun; 99(6):1023-8. PubMed ID: 15180720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical therapy of extraesophageal gastroesophageal reflux disease.
    Katz PO
    J Clin Gastroenterol; 2000 Apr; 30(3 Suppl):S42-4. PubMed ID: 10777172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current management of gastroesophageal reflux disease.
    DeVault KR
    Gastroenterologist; 1996 Mar; 4(1):24-32. PubMed ID: 8689142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastroesophageal reflux disease: pathophysiology and pharmacology overview.
    Dajani EZ
    J Assoc Acad Minor Phys; 2000; 11(1):7-11. PubMed ID: 10826019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical treatment of gastroesophageal reflux disease: options and priorities.
    Thomson AB
    Hepatogastroenterology; 1992 Feb; 39 Suppl 1():14-23. PubMed ID: 1349550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term cost effectiveness and long-term cost analysis comparing laparoscopic Nissen fundoplication with proton-pump inhibitor maintenance for gastro-oesophageal reflux disease.
    Cookson R; Flood C; Koo B; Mahon D; Rhodes M
    Br J Surg; 2005 Jun; 92(6):700-6. PubMed ID: 15852426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GERD management. Strategies recommended for primary care practice.
    Kuritzky L; Rodney WM
    Postgrad Med; 2001 Oct; Spec No():11-8. PubMed ID: 11868426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacological management of gastroesophageal reflux disease.
    Lowe RC; Wolfe MM
    Minerva Gastroenterol Dietol; 2004 Sep; 50(3):227-37. PubMed ID: 15729198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic strategies for treating gastroesophageal reflux disease.
    Vivian EM; Thompson MA
    Clin Ther; 2000 Jun; 22(6):654-72. PubMed ID: 10929915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decisions in diagnosing and managing chronic gastroesophageal reflux disease in children.
    Hassall E
    J Pediatr; 2005 Mar; 146(3 Suppl):S3-12. PubMed ID: 15758900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term gastroesophageal reflux disease therapy improves reflux symptoms in elderly patients: five-year prospective study in community medicine.
    Miyamoto M; Haruma K; Kuwabara M; Nagano M; Okamoto T; Tanaka M
    J Gastroenterol Hepatol; 2007 May; 22(5):639-44. PubMed ID: 17444849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determining the cost of gastroesophageal reflux disease: a decision analytic model.
    Holzer SS; Juday TR; Joelsson B; Crawley JA
    Am J Manag Care; 1998 Oct; 4(10):1450-60. PubMed ID: 10338737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Healthcare costs of GERD and acid-related conditions in pediatric patients, with comparison between histamine-2 receptor antagonists and proton pump inhibitors.
    Kothari S; Nelson SP; Wu EQ; Beaulieu N; McHale JM; Dabbous OH
    Curr Med Res Opin; 2009 Nov; 25(11):2703-9. PubMed ID: 19775195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cost-effectiveness analysis for the treatment of non-erosive reflux disease].
    Habu Y; Fukui Y; Maruno T; Hisatsune H; Kawai K
    Nihon Rinsho; 2007 May; 65(5):951-5. PubMed ID: 17511239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of GERD: medical versus surgical.
    Kahrilas PJ
    Semin Gastrointest Dis; 2001 Jan; 12(1):3-15. PubMed ID: 11215853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastroesophageal reflux disease--state of the art.
    Katz PO
    Rev Gastroenterol Disord; 2001; 1(3):128-38. PubMed ID: 12120180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management strategies for gastroesophageal reflux disease.
    Bak YT
    J Gastroenterol Hepatol; 2004 Sep; 19 Suppl 3():S49-53. PubMed ID: 15324382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.